The space of a few decades, at the end of the nineteenth and the beginning of the twentieth century, saw the establishment in France of "la pathologie infectieuse", a new discipline or medical speciality that gave rise to new clinical and laboratory practices and concepts.' Historical studies on this subject have focused, above all, on the theoretical aspects and have tended to attribute a privileged role to Louis Pasteur. The majority of French historians have simply analysed the "Pasteurization" of French medicine and implicitly assumed the validity of this analysis for western medicine and the overall importance of the French hygienist movement, the role of the "go-betweens" of Pasteurism's influence on Pasteurian "know-how" and "network".? In 1984, Bruno Latour broke with eulogistic historiography, but still maintained Pasteur's central role to the extent that he controlled the network that he had created, that is to say, the mediators between his laboratory, hygiene and the clinic. 3 But little has been said about these clinicians.4 It seems that this way of viewing them, as mere importers of Pasteurian ideas, neglects the fact that these practitioners themselves did laboratory work, using approaches different from Pasteur's, whether they worked on etiology, made use of bacteriological tools and appropriated clinical bacteriology to their own interests, and raised their own questions, not necessarily those of Pasteur's laboratory, in relation to their experiences as practising doctors.
for laboratory research: microscopy, histology, haematology, chemical analyses (especially urine) and pathological anatomy. During the same year, 1869, Bouchard agreed with Villemin's arguments concerning the "contagion of consumption". He knew the publications of Carl Wunderlich, Carl Rokitansky and Felix Niemeyer on this subject. Wanting to gather more information on German science and to meet Rudolf Virchow, he went to Berlin when Sigismond Jaccoud, Charles Adolphe Wurtz and Germain See were translating the works of German authors into French.'2 In 1870, Bouchard became head of the Bureau Central de l'Assistance Publique and, in 1872, assistant professor under Jean-Baptiste Bouillaud, who held the second chair of clinical medicine. In 1874, as a member of the hospital staff, he held the position of Director of Wet Nurses, before moving to the Bicetre Hospital (1876).
At that time, the theory of fermentation converged with the theory of parasitism: contagious and infectious diseases resulted from a fermentation, whose active agent within the organism was the "microzoaire", the "microphyte", or again, the "bacterium", the "vibrio", the "bacteridium" (motionless under the microscope), the "spirillum" (if the filament was helical) or the "spore", all of these names designating diverse forms of germs. In 1872, Georges Dieulafoy, Trousseau's intern, distinguished three categories of infectious and contagious diseases: (1) "clearly parasitic" diseases, or due to fungi (scabies, trichinosis, thrush, ringworm, etc.); (2) "septic affections" resulting from the rapid multiplication of "proto-organism-ferments" in the body, producing, according to the case, more or less severe poisoning of the affected subjects (septicaemias, puerperal diseases, typhus, etc.); and finally, (3) "virulent" diseases, sometimes closely resembling septic affections (smallpox, etc.) .'3 This represented an attempt to classify diseases by etiology.
The question of the patient's "receptivity" was also raised during the 1870s, but was not new; it remained wrapped in shadows and mystery whose individual variations were elusive. This question of individual predisposition dominated all pathology, regardless of whether the illnesses were specific or not. And doctors openly admitted their ignorance on this subject. How was it possible to understand such wide disparities of reactions among persons when exposed to the action of a germ? How and why did these "animated parasites" invade one organism and spare another, even when the latter had been the more exposed to the action of the germs? All these questions preoccupied doctors because they could not answer them.
Certainly, two things were generally considered: "the seed and the soil". A principle of infection or contagion was required, but subjects also had a variable tendency to become infected. This "morbid receptivity" was a particular property of the individual which rendered him sensitive, at a given moment, to infection or contagion. For Georges Dieulafoy, some individuals were resistant to the action of viruses and could expose themselves with impunity to contact with the virulent principle; this "immunity" could be complete or incomplete. Some people were completely refractory 12 Ibid., pp. 71-7. " Georges Dieulafoy, De la contagion, Paris, A Parent, 1872, pp. 118-23. The Clinician, Germs and Infectious Diseases to infections, others suffered only slight manifestations of the disease."4 This "immunity" was intriguing: certain individuals were resistant not only to contagion but also to the direct inoculation of the viruses. This mysterious receptivity did not seem to be a direct reflection of the individual's apparent strength or weakness. But over time, the immunity could also "run out", with the individual finding him-or herself receptive or again susceptible, for example, to a new bout of typhoid fever. These strange observations fitted imperfectly into the framework of "parasitic theories". Things were not simple and clinicians often had many diathetic types that they confidently ascribed to individuals and these were important in diagnosis and prognosis.
During these years, doctors interested in germs and viruses seem to have been struck by the disproportion between a possible cause, insignificant in appearance and often imperceptible, and its terrible effects.'5 How could these causes which were so "light" generate consequences so disastrous? The individual could be contaminated by the "smallest inoculum of virus", so tiny that it escaped detection by the senses and medical investigation, and yet this "virulent atom" was enough to upset profoundly the organism or even to destroy it. The virus or germ introduced itself without the person being aware, clandestinely and without pain, leaving no evidence of its passage for a while, then manifesting its presence and its action by a whole series of disorders and events of varying degrees of severity. The entire organism could be invaded: the skin, blood, as well as internal organs. Doctrines clashed in their attempts to explain such phenomena, or tried to combine various theories of germination and fertilization, fermentation, and accounts of animal and vegetal parasitism. In fact, there were different germ theories of specific diseases being debated in specific communities and places in the 1870s. '6 Emile Chauffard, professor of general pathology and therapeutics at the Paris Faculty of Medicine , complained in 1877 that the germ theory was "simplistic", "fashionable" and "invading". He stated, "It seems to have already conquered the entire class of specific illnesses, the majority of nosology, and tends obscurely to win over residents, who until now seemed to have avoided specificity. The pathology of fermentations has haunted and seduced doctors' minds for many years".'7 What struck Chauffard in the germ theory was that "the activity which creates the disease", and which up to that time resided in the ailing human organism, became, with the theory of germs, entirely attributed to the latter. This displacement of morbid activity seems to have disturbed Chauffard's conceptions. He was willing to accept the idea that the action of a micro-organism is limited to making a "morbific impression" on the individual that is powerful because it is slow; and that this impression, by affecting the "vital sense", provokes the eruption of the specific 14 Ibid., pp. 32-9 illness. But this scenario would have absolutely nothing to do with the multiplication of germs.
Therefore, much too quickly according to opponents like Chauffard, "parasitism" replaced the older concepts of certain spontaneous illnesses. Many doctors participated in this development, others looked on, surprised or critical. And yet, the etiology and pathogenesis of specific illnesses seemed, at least in the eyes of many doctors, to become easier to understand with the help of the germ theory. Furthermore, it was a true case of "popular success" denounced by the critics. These latter protested against "the prospectuses, which enthusiastically boasted about the properties of this or that parasiticide" intended to cure certain fevers, and against simplistic popularization of the topic.'8 But, here again, things are not simple. Microscopical observation and bacteriological techniques were far from identifying a germ for each specific illness, whether virulent or not. What was the cause, for example, of typhoid fever (whose micro-organism was not to be discovered until 1880 by C J Eberth)? In 1877, Bouchard reported his ideas on the etiology of typhoid fever to the International Medical Congress in Geneva. He listed chronologically opinions concerning this illness as follows: septic illness, zymotic illness, parasitic illness, contagious illness, virulent illness. For Bouchard it was a specific contagious illness, caused by a still unknown ferment or a virus. While on the staff at the Bicetre, he noted that, "If the virulent matter does not possess the morphological characteristics of a living being, it none the less is endowed with this strange power that enables it, with the aid of living matter, to create molecules that are similar to it, and recognizable as having the same physiological activity and also capable of indefinitely reproducing similar specific molecules". '9 It had been observed that contagion occurred exclusively by contact with the faeces of people infected with typhoid fever. Contagion could be passed on by soiled hands and/or clothing, contaminated drinking water or milk (this contamination could be caused by washing the milk buckets with dirty water, or by the dairyman's hands). According to Bouchard, there was no contradiction between contagious and infectious phenomena in typhoid fever. The germ was equally capable of developing both outside and inside the organism. "The germ, finding itself in a putrid household, can thrive there; from there it can pass into a human body and cause illness by multiplying itself; it can then pass from a sick individual to a healthy organism. This concept is only a hypothesis."20 Without contradiction, infection and contagion would therefore be explained by a single cause: an infectious illness, when the germ originated in a putrid household; a contagious illness, when the germ had already passed through a living organism. This concept could explain small epidemics, sporadic cases and so-called spontaneous cases. Bouchard remained cautious, and considered that, before discussing this germ, it was necessary to demonstrate its existence and to attempt to cultivate it. Once the The Clinician, Germs and Infectious Diseases "morbific agent" was discovered, then the experimental pathophysiology of typhoid fever could be studied.
On 30 April 1878, at the Academy of Medicine of Paris, Louis Pasteur presented a paper on 'Germ theory and its applications to medicine and surgery'.2' This interpretation of disease as a coherent entity, in which lesions and symptoms were linked to an etiology, incited more attempts to reproduce experimentally septic and virulent illnesses in the laboratory. The idea that living germs could be involved in certain illnesses also led to revisions and modifications in the interpretation of existing clinical entities. This type of work, involving the reconstruction of categories and the classical tasks of medicine (this time based on etiology, which became a central element), was not a primary task for the Pasteurians. During this period, whole fields of pathology were nosographically re-evaluated, in parallel with the development of a burgeoning bacteriological medicine. Bouchard's educational and early clinical experience came at a time when Claude Bernard's physiology was ascendant, and when Pasteur's early work on germs and Lister's focus on antisepsis was leading to new thinking about infection.
The Laboratory of Bacteriological Diagnosis At the end of the 1870s, Bouchard, as we have seen an inveterate reader of both French and German clinical research, sought to link his medical practice with the new approach to the etiology of infectious and contagious diseases. He intended this nosographic reconstruction to serve as a diagnostic aid. He closely examined the cases and the systematic search for germs in different diseases and found fault with the axiom: one germ-one disease. In fact, to the concept of morbid entities caused by the same specific microbes, another, less "simple" one had to be added: apparently identical morbid processes, at least in terms of their first manifestations (such as sore throat, meningitis, endocarditis, bronchitis, etc.) could be provoked by different germs or by the association of several germs.
Bouchard was particularly interested in the microscopical examination of various samples taken from the patients in his care. Medicine, 1879 Medicine, -1910 ). An annex to the men's ward was set up as a laboratory, where he and his residents examined specimens under the microscope and performed urine analyses. This small room was cluttered with glass tubing, test tubes, funnels and jars, and a bed for the patient to use while samples were being taken. Each patient's urine, regardless of the illness, was collected every day, sent to the laboratory and subjected to chemical and microscope analyses. Bouchard and his residents sought to verify the major principles, widely discussed at the time, of penetration through the pharyngeal crossroads of the "microbial poisons" implicated in infections of the tonsils and nephritis of tonsillar origin. They also sought to localize infectious agents and their poisons in certain fluids, and in the arthropathies during infectious or toxic states that Bouchard named "pseudo-rheumatisms".
In Bouchard's department, every time a purulent abscess or effusion appeared suddenly, the resident had a standing order to The Clinician, Germs and Infectious Diseases Experimental research had, in his opinion, refuted false theories, rounded out inadequate doctrines, clarified obscure points, but it had not "shaken the edifice" based on the observations of clinicians. Bouchard was convinced that clinical and experimental medicine should be united rather than opposed. The "pathologie infectieuse" was not based solely on bacteriology. The reorganization was more general and more complex, in continuity with long-standing anatomoclinical knowledge. The clinicians associated a "germ" with the signs, symptoms and lesions detected on the living patient. Progressively, a clinical symptomatology of "infectious diseases" was elaborated, diagnostic procedures evolved, techniques for sampling and "tracking" the germ (which implied new tools and new approaches) were perfected, all in parallel with the development of bacteriological techniques to isolate and culture germs.
For example, following the lead ofWunderlich in Germany and Jaccoud in France, highly detailed studies of temperature curves were conducted.26 Doctors gained valuable insights from these in terms of diagnosis and prognosis. Examination of temperature curves, associated with other clinical symptoms, led to the search for particular germs in fluids or tissues. Clinical practice focused on the systematic search for signs accompanying "fever": shivering, elevated respiratory and cardiac rates, sweating, increased size of the spleen, the appearance of the tongue, swollen glands, etc. Clinical observation, the comparison of "morbid processes", and consideration of the conditions of their appearance were the elements on which doctors based their presumptions of the infectious nature of an illness. Bacteriology added an element of certainty or strong probability to the diagnosis.
The idea of submitting the clinical diagnosis to the "verdict" of a bacteriological examination progressively took hold at the end of the 1880s and into the 1890s: this new way of approaching illness modified clinical practice and its relationship with the patient's body: he or she was "inhabited" by microscopic germs which circulated and proliferated. The invisible evil, coming from outside, could progress in the essential fluids of the body and insidiously eat away at the individual. From then on, germs were "tracked" by taking samples at the patient's bedside from the throat, sputum, blood, pleural and spinal fluids, etc., with which the culture media were seeded. This was the era of perfecting "blood cultures", later to be called haemocultures, which also implied technical innovations (the invention, for example, of a syringe that could be completely sterilized);27 the perfection also of "spinal" or lumbar puncture. laboratory medicine became established in a more or less improvised manner within the very same hospital department. This laboratory was not a Pasteurian laboratory. In this place, the work could be seen as a routine microscopical pathology, an extension of the clinical gaze. But this laboratory was also a place for diagnostic analysis. Here again, the tools used were above all those of German bacteriological medicine: Koch suggested the use of solid media, which would allow pure bacterial cultures to be obtained easily; he perfected special instruments for working on these media: platinum handles and loops, etc. But what particularly marked the French clinicians was the discovery of the tuberculosis bacillus (Koch, 1882). As of 1883, Bouchard and Dieulafoy (chief physician at Saint Antoine Hospital) encouraged their residents to search for the bacillus in the victims' sputum samples.29
Sputum examination and the search for the tuberculosis bacillus was also of great service to private practitioners. The presence of the bacillus enabled the practitioner to confirm the diagnosis of pulmonary tuberculosis early on. The search for the bacillus was, according to authors of the period, "of capital importance and gives a pathognomonic sign there where auscultation does not allow the presence of tuberculosis to be affirmed".30 If this germ was found, then isolation could be prescribed at an early stage, perhaps avoiding the transmission to other members of the family.
For sore throats, it was proved that the clinical signs had an illusory value from a diagnostic point of view, and that only the bacteriological examination enabled the identification of the microbe responsible for the disease: diphtheria bacillus or other germs (streptococci, pneumococci). In the former case, the anti-diphtheria serum was administered immediately (from 1894 onwards). In the others, local antiseptic treatment sufficed. Search for tuberculosis bacillus in sputum and diphtheria bacillus in pseudomembranes constituted crucial aspects of public health.
Numerous discussions and debates took place at the end of the century at the Academy of Medicine of Paris on the subject of diagnosis and the nosological classification of sore throats. According to Dieulafoy (professor of medical pathology, 1886-96), the actual and complete diagnosis of a sore throat, the one determining prognosis, prophylaxis and treatment, entailed assigning a specific etiology to the symptoms.3' The anatomoclinical classification of non-diphtherial sore throats was not invalidated but rather completed. The different clinical forms of sore throat were not associated with a single infectious agent, and equally, a single germ seemed to be able to give rise to different forms of sore throats. Clinical observation, therefore, retained its important role: a red pharynx, swelling of the tonsils, sometimes oedema of the pillars of fauces, the appearance of a veil or a uvular aspect, the presence of a "creamy white coating", etc. It situated the sore throat within the anatomoclinical classification and constituted the foundation for diagnostic and etiological procedures. The Clinician, Germs and Infectious Diseases
The laboratory therefore became a necessary auxiliary to clinical medicine and associated diagnostic and experimental research. It was the melting pot of diagnostic, pathophysiological and therapeutic studies directly linked to the clinical observations of patients treated in the department. Here we are a long way from the "pure" research laboratory far from the patient. With bacteriological examinations, the clinic-laboratory association became particularly close. This collaboration commanded a large consensus at the end of the nineteenth century. Dieulafoy and Bouchard proclaimed that bacteriological diagnosis made in the laboratory was the true extension of clinical medicine. The clinic became coupled to the laboratory, without the latter edging out the former.
At the same time, Bouchard, influenced by Bernard's ideas on vitalism and mechanism, as well as the great physiologist's studies of the vaso-motor centre, articulated during the first years of the 1890s a theory of infection and immunity that lay between French cellular and German humoral interpretations.32 This showed how a clinician like Bouchard interpreted the effects of microbes on the body. This is another claim for Bouchard's general intellectual debt to his estranged neighbours, as opposed to his closer pastorian ones. In his book, Actions des produits secre'te's par les microbes pathoge'nes (1890), the references concerned especially German authors such as Karl Flugge, Ottomar Rosenbach, Rudolph Nissen, Edwin Klebs, Hans Biichner and Vladimir Wyssokowitsch.33 At the beginning of the twentieth century, "infectious diseases" were classified; they became a class of morbid entities in their own right. In 1903, Bouchard declared that modern research on etiology had only slightly modified previous concepts based on anatomoclinical medicine and, in the majority of cases, had in fact confirmed them.4 Numerous diseases had been individually identified before the discovery of microbial agents. The discovery of Koch's bacillus nevertheless gave a strong basis to the earlier concept of tuberculosis and linked less precisely identified lesions to it. Despite its demonstration of pathogenic agents (mostly by the German school), clinical bacteriology was not yet able to provide a solid basis to rectify nosography. Bouchard Alain Contrepois character. He pointed out the singular existence of one morbid group, "infectious diseases", whose emergence to autonomy had been remarked by observers for many years. In this group, he clearly distinguished between "specific infectious illnesses" with well-defined characteristics, whose etiology amounted to "determining the morbid group", and "non-specific infectious diseases" caused by various microbes (often "common" bacteria living in skin and mucous membranes), which gave rise to various clinical manifestations, given below. Yet, the dominant element in the nosographic study remained the "morbid localization".36 Bouchard's classification was as follows:
1. INFECTIOUS DISEASES Spec.ific. These diseases could be of: (1) bacterial origin (typhoid, carbuncle, glanders, cholera, dysentery, plague, diphtheria, blennorrhagia, soft chancre, flu, dengue, whooping cough, mumps, syphilis, leprosy, tuberculosis, bacterial pseudotuberculoses); (2) vegetal origin (actinomycosis, botryomycosis, aspergillosis); (3) animal origin (malaria, trichinosis); or (4) unknown origin: fevers associated with eruptions such as yellow fever, rabies, exanthematous typhus, acute articular rheumatism, cancers and neoplasms, leukocythemia). Non-specific (bacterial origin). This group of diseases included: (1) septicaemias and pyemias, and (2) exudative, suppurative, degenerative, pseudomembranous, ulcerous, and gangrenous inflammations (organs, tissues, systems).
PARASITIC DISEASES
These afflictions could be of: (1) bacterial origin (?); (2) vegetal origin (trichophytosis, favus, alopecia areata, pityriasis versicolor); or (3) animal origin (taenia, Bothriocephalus (pseudophyllid tapeworm), hydatid cyst, ascarids, oxyuris, scabies, pediculosis).37
Thus, between Grisolle's 1862 classification and that of Bouchard published in 1903, a broad range of infectious diseases that constitute the field called in France "pathologie infectieuse" had been recognized and categorized. Grisolle put smallpox and measles with "fevers"; mumps and roseola with "inflammations"; rabies, carbuncle, and syphilis with "poisonings"; and leprosy, phthisis and tubercles with "organic transformations and pathological morbid products".38 Bouchard put all these afflictions into a single class-"specific infectious diseases", which were always caused by the same germ. Concerning the group of specific infectious diseases of "unknown origin", he specified that, "For the moment, even though we have not succeeded ... in detecting their pathogenic agents, we are sure that they are very Based on the evolving "microbial theory", physicians brought to the clinical and experimental study of antiseptics a qualitative change-these agents were henceforth progressively etched into the rationale of therapeutic rules that took into account in vitro findings, the toxicity of the products in animals and the "pharmacological" data obtained in patients. of Joseph Lister, who introduced his method of antisepsis to eliminate the presence of germs from wounds and surgical operations.43
On 3 August 1877, the Gazette Hebdomadaire published an article entitled, 'Notes on the use of real creosote for the treatment of pulmonary phthisis', by Bouchard (then working at the Bicetre Hospital) and Gimbert (in Cannes)." They had met in Charles Robin's laboratory, where Gimbert prepared drugs.45 In 1877, the germ responsible for tuberculosis had not yet been identified, but Bouchard and Gimbert had been prescribing "antiputrifactive" creosote empirically to treat "consumptive and phthisical" patients since 1874." This smelly antiseptic had long been used and was distilled from wood tar after carbonization. In 1870, C A Wurtz estimated that many commercially available creosote preparations contained only phenol or a mixture of phenol and cresylol.47
Because Bouchard considered the treatment of tuberculosis to be the major problem confronting doctors of his era, he multiplied his therapeutic trials against this disease that "decimated humanity". Bouchard attacked the "tubercle" eight years before Koch isolated the bacillus responsible, but also eight years after the 43 The Clinician, Germs and Infectious Diseases publication of Villemin's studies. In fact, for the treatment of phthisis, he tried to rehabilitate creosote, the medication that Reichenbach had used in the middle of the century. Bouchard and Henri Gimbert attributed the failures that had led to the abandonment of this product to the mode of administration, "illusory or dangerous", or "to an error in the nature of the substance used rather than the medication's lack of efficacy".48 Bouchard justified the empirical or even "experimental" use of drugs in phthisis, a severe disease. Confronted with severe diseases or those reputed to be incurable, experimentation is permissible, some say obligatory. One resists with at least some difficulty the temptation to use new therapeutic agents that, by one of their properties, seem able to fight advantageously against such a harmful element.49 Thus, Bouchard had creosote prepared by the pharmacist, M Mayet, according to Reichenbach's formula, and then by the hospital pharmacy according to that of Georges Dujardin-Beaumetz.50 He studied creosote toxicity in animals and its physiological effects in man before starting clinical trials in phthisical patients. Bouchard and Gimbert administered creosote orally in high doses (up to 3.6 g per day), which produced, according to them, "in favourable cases, the diminution of expectoration then cough, improvement of physical signs, calming of the fever, restored vigour, attenuation of sweats".5' Creosote being a "strong caustic", they renounced using powders, pills and suspensions and chose to use solutions (alcohol solvent) extensively diluted in water or oil (aqueous solutions 1/1000, oily solutions 1/100). Thus taken, the medication "ceases to be toxic" and its administration is limited only by the "impossibility of the patient to ingest too large quantities of liquid".52
The authors treated 93 patients with "pulmonary tuberculization" by having them swallow two to four spoonfuls of the mixture per day during a "rather prolonged" period. Although the bitterness of the medication often provoked the "resistance of patients" at the onset, it was well tolerated and was regurgitated "by only one of our phthisical patients".53 The results indicated 25 "apparent cures", 29 "improvements", 18 "failures" and 21 "deaths". Even though the authors hoped that the cures were permanent, they preferred the term "apparent cure" because previous experience had shown them several times that these cures were "fragile".4 Bouchard took the precaution to conduct a test in a healthy adult for thirty-four consecutive days: every day clinical parameters were recorded (temperature, pulse, respiration, diuresis, appetite, etc.) and chemical analyses of urine were performed (urea, uric acid, phosphoric acid, chloride, colouring agents). No effect of creosote was noted 48 Bouchard, and Gimbert, op. (Dujardin- in the healthy individual. This was one of the first "clinical trials" of an antiseptic therapy for phthisis. The results of the study were contested and elicited sceptical and even hostile reactions that markedly affected Bouchard.
Under his direction, his students learned to unravel for each particular case the therapeutic indications, based on a careful analysis of the chronological order of "morbid accidents". "What overrides all in therapeutics is knowledge of their indications, which arises from our general notions ofthe disease and the understanding that we have ofthe special circumstances surrounding a particular case."55 Therapeutic principles are determined by the clinical specificities of each individual case. Certainly the therapeutic indications can be multiple, but they do not all carry the same weight. Those that lead to a truly curative action "rely on understanding the major pathogenic principles".56 Bouchard attempted, in particular, to introduce the microbial etiology of the infection into the pathogenesis, so that it permeated both clinic and therapy.
During the following years (the early 1880s), Bouchard became highly interested in what was happening in Germany: C Weigert was using aniline to demonstrate the presence of bacteria in tissues; H Caro had synthesized methylene blue; F J Cohn was working on the selection of bacterial species by modification of the culture media; Robert Koch was doing research on the carbuncle and the etiology of kidney infections (Leipzig, 1878) . He read the Guide for antiseptic treatment of kidney affections, by J N von Nussbaum, that had been published in Stuttgart in 1878; he also knew that A von Bayer had synthesized indigo in 1879, and that C J Eberth had isolated the typhoid bacillus the same year. Above all, he was interested in the discovery of the tuberculosis bacillus announced by Koch in 1882.57 In 1884, during the International Medical Congress in Copenhagen, Bouchard made known more precisely his opinion concerning the utility of antiseptic treatment of infectious diseases. In contact with surfaces, external or internal (skin, mucosae, abscesses opened by drainage), antiseptics can act slowly and continuously to neutralize little-by-little the germs that form there incessantly; according to him, insoluble chemical agents were preferable. Having established that antiseptics prevented infections in surgery, he then considered the conditions under which these products could be used in medical therapeutics. His starting point was indeed the clinic. Depending upon whether the infection was local or generalized, he considered not only the antibacterial action of antiseptics in vitro, but also the patient's tolerance, the toxicity and the elimination of the drug by the organism.
Within tissues, in humours, the problem appeared arduous for Bouchard: the intruder inhabits the organism but it is impossible to "disinfect" or sterilize the whole body. In this situation, how can one attack the microbe without harming the host? For antiseptics to confront infectious agents, soluble substances, less toxic to stress the need to ensure the integrity of renal function before administering active agents which, even at low doses, could become toxic in the context of abnormal kidneys. He carefully studied the conditions of use of quinine, the action of salicylic acid on "renal secretion", the slow elimination of potassium bromide by the kidneys, etc. The questions asked by Bouchard and his clinical practice were very different from those posed at the same time by Pasteur (a chemist) and Emile Roux (a medical doctor).59
In the course on general pathology that he taught at the Paris Faculty of Medicine in 1887-88 (published in 1889), Bouchard summarized his ideas concerning the therapeutics of infectious diseases.' He wondered if bacteriological discoveries had several consequences for drug therapy. He noted that some eminent men resisted the idea that the germ theory could exert an influence on antimicrobial therapy. Several local disinfections were easily accepted for skin, abscesses, and joints, but few physicians attempted to disinfect a uterus or the intestines. As for general antisepsis, it would be "a dream, a chimera, a great illusion".6' The fundamental argument was the following, "A substance toxic to a fermentative vegetal cell will always, and even more logically, be toxic to a human nerve cell".62
This opinion was almost unanimously expressed by experimenters and even clinicians, and the same objections were heard, according to Bouchard, in the laboratory of physiology at the Sorbonne, in the laboratory of comparative pathology at the Faculty of Medicine, in Pasteur's laboratory and in numerous clinics. Our adversaries oppose us with the eternal sophism according to which the antiseptic will always kill the patient before killing the microbe. However, we do not necessarily aim at killing the microbe; this task does not belong to us but to the living organism that is fully equipped to cause the death of the microbes. Above all, we want to influence their rampant 8 In this same year (1884) in Germany, Robert Koch also tested a certain number of disinfecting chemical substances in vitro and notably recommended mercuric chloride for disinfecting wounds. Taking the lead from Pasteur's studies on the attenuation of anthrax and chicken cholera germs, he tested certain chemical substances in an attempt to inhibit the growth of the tuberculosis bacillus. Around 1888, he noted the efficacy of certain products in vitro but emphasized the absence of an in vivo therapeutic effect in the tuberculous guinea pig.
59Indeed, in 1885, Pasteur and Roux were working experimentally for the first time on a human pathology, rabies, and on a treatment for this disease that affected a few rare individuals who had been bitten by rabid dogs. The responsible germ had not yet been isolated, and a means of attenuating the "virus" and eliminating its "malignancy" while conserving its integrity remained to be found. Roux and Pasteur finished by suspending the aseptically removed spinal cords of rabid dogs in a flask filled with warm dry air for fifteen days. To test the decline of virulence, they gave rabies to a healthy dog by inoculating it with spinal cord homogenates directly into the brain after trephination. Thus, we enter the realm of experimental pathology, with attenuation of the virus and therapy with a most unusual "vaccine" because it had to treat the disease but not prevent its development. This was a sophisticated and complex experimental biological methodology. The proliferation and their ability to function. We block the rapidity of their multiplication, so that there remain fewer to destroy. We can, by diminishing the violence of the infectious agents, give the ailing organism the time to react against them and to resist them victoriously . . .63 If quinine triumphs so rapidly and surely against malaria, it is, I think, because it possesses a direct noxious action on the infectious flagellum and not because of a suspected general activity against fevers, for there are many fevers against which quinine is impotent; nor are its antithermal properties at work, since quinine does not lower the temperature of healthy men ... I say that specific medications are the only ones that cure and that the majority of specific agents are antiseptics. Certainly, a sick man can be cured of many diseases without our giving him specific agents; but in such a case, he cures himself alone and the therapeutic means that we use can only, at best, help him cure himself. In contrast, when the cure is truly attributable to the physician, it is because the latter has a specific agent at his disposition.'M Bouchard asserted that to assist a patient in this fight against an infectious agent, it is not always necessary to kill the microbe. The organism takes responsibility, so long as it does not have to fight under too adverse conditions; it can manage against a small number of germs, but its resistance drops when confronted with many.
It is almost always impossible to kill, without endangering the patient, the microbes inhabiting the latter; it is possible and often easy to influence the number of microbes by slowing their multiplication....65 It would be an error to believe that microbes are, in general, our enemies.
Indeed, on the contrary, the mass of species of the microbial world are on our side. Without microbes, life would cease to exist on the surface of the earth, it is they who render possible animal and plant life; they are the indispensable intermediaries in the circulation of matter.66
For Bouchard, what antiseptics do in vitro, they should also accomplish in a wound, in a normal or pathological cavity, in the thickness of a tissue, "What is open to debate is whether antiseptics can slow the proliferation of microbes on or in tissues, not when they are deposited directly, but when they arrive through the circulation."67 This latter remark clearly shows the importance that Bouchard accorded to the idea of 'General antisepsis', the title of the thirty-third lecture in his course.68 According to him, in order to judge the therapeutic value of an antiseptic, it must be established that it shortens the duration and counters the effects of an infectious disease. The argumentation is clearly clinical. But before undertaking trials in patients, he ruled that the antiseptic potency of each chemical substance had to be evaluated in vitro. He devised an "antiseptic-equivalence test" and specified three levels of concentration: one that slowed microbial growth, one that stopped its growth, and one that killed the microbe. Toxicity must also be evaluated in animals ("toxic-equivalence" test) creosote, phenol, thymol, resorcinol, naphthol, b-naphthol, methylnaphthol. To determine therapeutic and toxic equivalents, he injected doses intravenously. The dose he sought to identify was not the one introduced here or there in the organism, but the one that was distributed throughout the tissues at the moment that the first physiological effect appeared. One must know not only what was introduced into the body or ingested, but what was really absorbed and present when intoxication accidents arose. To avoid the disadvantages of the digestive tract and subcutaneous routes, Bouchard retained for experiments the intravenous route via a peripheral vein. By this means, he surmised that the antiseptic substance would be distributed instantly and uniformly throughout the organism.
These experiments should be conducted on the same animal species so that the results can be compared; I use rabbits because injection in a marginal ear vein is easy to do. It is necessary to inject the product rapidly (approximately 2 seconds) and the volume to be injected should not be too large. I recommend sterilized water containing sodium chloride (7 g/l) as the dissolving liquid.69
Therefore, "therapeutic" equivalents were the doses at which the medications started to "act" without the risk of being toxic. Thus, practitioners distinguished between antiseptics for "external" (skin, wounds), "local" (mucosae, cavities) and "general" use.
External use: mercuric chloride and other mercuric preparations, potassium permanganate, ethyl alcohol, silver nitrate for the eyes, iodoform for wound dressings and suppurating surfaces, certain dyes, tincture of iodine. Some of these substances had already been used for a long time.
Local use (mouth, throat, nose, ears, vagina, etc.) : dyes like aniline or fuchsin (they were also used "internally" for the treatment of albuminous nephritis; they colour urine red but are well tolerated); 5 per cent resorcinol solution for swabbing, gargling and spraying sore throats, and as a salve (10 per cent) for skin diseases: "styrone" (a derivative ofdioxybenzols) used to treat middle ear infection; camphored and "sulforicinated" naphthol for swabbing simple and pseudomembranous sore throats and furunculoses.
In the intestinal canal: insoluble or poorly soluble antiseptics, such as naphthol, naphthol salicylate and benzonaphthol, combined or not with bismuth salicylate, for gastro-enteritis.
General or internal use: quinine was used to treat malaria (classed with the specific antiseptics); naphthalene, b-naphthol and creosote for other infections.
69Ibid, p. 220.
At the end of some medical charts or between the lines of a description of particular administration modes for antiseptic substances, it is possible to detect a taste for "radical" warfare against germs: the aim is the "extermination" ofthe germ, regardless of the difficulty for the patient. They prescribe, for example, parenchymatous injections, certainly painful for the patient. At the same time, this type of treatment sometimes assumed the aspect of a sort of necessary atonement. Did the patients, perhaps in a desperate quest for new remedies, eagerly seize as their own the idea of a medicinal "antidote" against the infecting agent in which the doctors put their trust: a specific remedy with the ability to destroy effectively the disruptive germ?
The disease was no longer considered a divine punishment for which each individual felt more or less responsible. The "invention" of microbes seemed to relax patients in the sense that it freed them of guilt. But, on the other hand, it filled the known universe with powerful and invisible enemies-defining a hostile and threatening world. The medication was a new rational chemical weapon used for a specific task. It raised high expectations in the prescriber and the treated patient.
When Bouchard suggested antisepsis of the lungs, it was a step on the path towards general antisepsis, towards the battle against infectious agents everywhere in the organism, in blood and tissues. At the end of the century, it was accepted that bronchitis and pneumonia were generally caused by pneumococci or streptococci, and that antiseptic therapy was required. To achieve antiseptic penetration directly into the respiratory apparatus, Bouchard proposed inhalations and sprays that had been used for a long time, and interstitial or parenchymatous injections into the lungs.70 He also attempted to convey the antiseptic directly to the lungs through the general circulation by introducing it into the digestive tract, injecting it into subcutaneous tissues or into the rectum, or even achieving penetration into the blood by pulmonary absorption.
In several patients, he used long Pravaz needles plunged two or three centimetres through an intercostal space to deliver to the pulmonary parenchyma sodium benzoate, concentrated potassium iodide, naphthol or mercuric chloride. The medication penetrated into some "intimate" regions at the interior of the organism and it is difficult to imagine what the patients felt: probably both pain and perhaps a sort of rupture of their bodily integrity because of the violent penetration and sharpness of the needles. An alien substance that could not be digested or rejected had been deposited within them. But their illness had to be very severe for such extreme treatment to be given. Bouchard admitted that more studies would be needed before the procedure could be used routinely in practice. In the meantime, he prescribed orally-administered general antisepsis with naphthol, naphthol salicylate, benzonaphthol, etc.
He attempted local antiseptic treatment of acute pneumonia with interstitial injections, but encountered formidable obstacles: haemoptysis and pneumothorax. France', in Ilana Lowy (ed.), Medicine and The Clinician, Germs and Infectious Diseases According to him, an insoluble antiseptic would have the advantage of fighting against the infectious process by its constant contact. "I gave injections of naphthol in an alcohol solution but only to healthy animals."'" Furthermore, to obtain antisepsis of the airways, Bouchard used medications that, introduced into the blood either by the digestive tract or other routes, "carry out general antisepsis first and then local antisepsis, when the blood brings them to the lungs, and they are eliminated by the alveolar surface or the glands of the bronchial mucosa".72
For pulmonary tuberculosis, other than aerotherapy, Bouchard first used vaporization and spraying (a vaporized solution of creosote in alcohol and glycerine) to bring antiseptics into contact with the deep parts of the respiratory apparatus. However, he realized that the medication undoubtedly did not penetrate into the lung in the form of liquid particles and that the favourable effect obtained was probably a result of the saturation of the air with the creosote vapour. Gimbert, for his part, vaporized the patients' rooms overnight with approximately 30 g of creosote in a bath of heated water. In this way, he "obliged" his patients to inhale the substance, "so that it penetrated into the blood across the pulmonary parenchyma",73 and he thought this approach could obtain local and general therapeutic antisepsis at the same time. Some physicians also sprayed turpentine or eucalyptus oil (it is worth noting the continuing importance of a disinfecting odour). 74 However, Bouchard thought that external means of treatment were insufficient for a disease as profound as tuberculosis. It was important to act within the parenchyma. To obtain antisepsis of bronchi and lungs, he considered pouring solutions directly into the bronchi by puncturing the trachea, rather than using sprays. But preliminary experimental studies were far too inadequate to permit this mode of administration to humans. "Into the trachea of rabbits, I injected bnaphtholated (0.2 g/l) saline (7 g/l) at a flow rate of 10 ml/kg/hour. This administration did not provoke any problems but must be tested in animals with a pulmonary infection."75 Robert Koch had already announced his discovery of the tuberculosis bacillus ten years earlier when Edouard Louis Trouessart published his book on antiseptic therapeutics.76 For Trouessart, who constantly referred to Bouchard's studies, tuberculosis was difficult to cure because of its slow and insidious evolution, and the localization of tubercles in the pulmonary parenchyma. An "energetic" treatment was necessary: iodoform pills alone or associated with creosote.77 Pills or granules seemed to represent the ultimate stage of concentration and purification of a crude material, the power of miniaturization. In addition, pills had the virtue of being rapidly and totally assimilated; it sufficed to swallow them with a little water. The same year (1892), in England, Thomas Lauder Brunton thought it possible "that amongst the enormous numbers of antiseptic compounds we may yet expect to find many drugs which may be useful as disinfectants in the blood and tissues".78
However, creosote toxicity was a source of uneasiness for physicians who also had reservafions about certain methods of administrating this substance: Charles Fernet, for example, decided to forego "stomachal ingestion" of creosote because of its "disagreeable" taste and its "irritant action on the gastric mucosa and the dyspepsia which could result".79 Thus, according to this staff physician at the Hopital Beaujon, one had to admit that creosote was not a panacea. He hoped a "truly effective" vaccine or remedy would be found.80 Many other doctors at this time denounced the misleading seduction of chemical therapy for tuberculosis and preferred aerotherapy, diet and rest.
For oral administration, Bouchard dissolved the antiseptic in oil, and the patient swallowed one or two spoonfuls morning and evening. Because cod liver oil was often even more disagreeable than the medication, Bouchard sometimes used beechnut oil. He paid attention to the tastes of each patient. "One of my patients had the idea of using butter as the excipient. He took the medication in voluminous pellets enveloped in unleavened bread."'8' Henceforth, Bouchard proposed ingesting the medication in this manner to other patients in his ward.
Antisepsis of the digestive tube seems to have preoccupied Bouchard for a long time. According to him-but it was a widespread idea-from the mouth to the anus, the digestive tube was a receptacle for poisons. Metchnikoff even saw it as the reason for the shortness of human life. The typical example was the intestine of typhoid patients and Bouchard conducted various trials to find medications that, without being too irritating or toxic, could be administered to these patients to disinfect their stools. The microbe of typhoid fever had been identified: Eberth's bacillus (discovered in 1879 and isolated in culture by G Gaffky in 1884). Bouchard could only "hope to disinfect the large intestine" by first obtaining antisepsis of the upper portions of the digestive tube. He initially had the patients ingest a mixture of charcoal and sulphur. Small doses of the antiseptics had to be taken frequently, every three to four hours. He prepared a suspension of charcoal and sulphur in glycerine, but this mixture was hardly appetizing. Prostrate typhoid patients swallowed the concoction slowly and incompletely. Bailliere, 1902 , pp. 261-82. pharmacology', Bull. Hist. Med, 1970 80Fernet, op. cit., note 79 above, p. 11. 518-38, p. 535. 81 Bouchard, op. cit., note 42 above, p. 292. 7 Charles Fernet, 'De la creosote dans le traitement de la tuberculose pulmonaire', The Clinician, Germs and Infectious Diseases Paul Le Gendre related that visitors to the wards were surprised to see the patients' mouths and chins smeared with the black or yellow mixture.82 This was even made the brunt of jokes by interns and residents in other wards. But Bouchard obliged the visitors to attest to the fact, by having them smell the bedpans, that the diarrhoea of these typhoid patients was as odourless as it was black, and that, under the microscope, the numbers of bacteria present in smears of these stools decreased along with their deodorization. The patient's tongue was perhaps black, but it was humid and the abdomen was soft.
Bouchard's experiments tested a series of insoluble or poorly soluble chemical agents that were reputed to be disinfectants. In 1889, Bouchard wrote, At the Copenhagen Congress, I formulated the principles of true antisepsis of the digestive tube. The antiseptic must be insoluble, so as not to be gradually absorbed as it continues its route, and so that it can exert its action along the entire length of the intestine to the anus.
For a long time, naphthalene, despite its disadvantages, was my preferred antiseptic; I replaced it with b-naphthol.83 For the patients, taking these medications was undoubtedly very difficult. The odour of naphthalene is repulsive and its taste is caustic; it can be swallowed only when embedded in unleavened bread, i.e., in the form of a "pellet". But some experiments showed that naphthalene could induce cataracts in rabbits and this therapy was discontinued.
For Bouchard, b-naphthol did not have the disadvantages of naphthalene. In humans, a dose of 1.5 g was needed to obtain adequate antisepsis in ordinary cases; for typhoid fever, 2.5 g were needed. "I have even given 4 to 6 g without side effects."' He divided the daily dose into 0.5-g fractions. Here again, he prepared the dose in a pellet of unleavened bread to protect the buccal and pharyngeal mucosae from direct contact, which provoked an "intense burning sensation". When antisepsis had to be obtained as rapidly as possible, Bouchard was able to achieve "complete deodorization of the stools" in three hours, by shortening the time interval between doses.85 Bouchard retained the mixture of b-naphthol and bismuth salicylate for digestive tube antisepsis.
This therapeutic research, conducted in the laboratories integrated with the hospital departments, reinforced the continuity between the patient's bed and the laboratory. Clinical treatment of infectious diseases with antiseptics became part and parcel of a complex medical practice, and there was no reason to make it a competitor of Pasteurian serotherapy; they were two different things. It seems that the role of the clinical contribution to the invention of treatments, for example, had been systematically swept aside. 
